Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes

BACKGROUND: We recently reported that short-term treatment with liraglutide (20.0 ± 6.4 days) reduced body weight and improved some scales of eating behavior in Japanese type 2 diabetes inpatients. However, it remained uncertain whether such liraglutide-induced improvement is maintained after discha...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Fujishima, Yuya, Maeda, Norikazu, Inoue, Kana, Kashine, Susumu, Nishizawa, Hitoshi, Hirata, Ayumu, Kozawa, Junji, Yasuda, Tetsuyuki, Okita, Kohei, Imagawa, Akihisa, Funahashi, Tohru, Shimomura, Iichiro
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2012
Aiheet:
Original Investigation
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3459720/
https://ncbi.nlm.nih.gov/pubmed/22973968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-11-107
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia